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Abstract 
Short oligonucleotide sequences are now being widely investigated for their potential therapeutic 
properties. The modification of oligonucleotide termini with short fluorinated residues is capable 
of drastically altering their behavior in complex in vitro and in vivo systems, and thus may serve to 
greatly enhance their therapeutic potential. The main goals of our work were to explore: 1) how 
modification of STAT3 transcription factor-binding oligodeoxynucleotide (ODN) duplexes 
(ODND) with one or two short fluorocarbon (FC)-based residues would change their properties 
in vitro and in vivo, and if so, how this would affect their intracellular uptake by cancer cells, and 2) 
the ability of such modified ODND to form non-covalent complexes with FC-modified carrier 
macromolecule. The latter has an inherent advantage of producing a 19F-specific magnetic 
resonance (MR) imaging signature. Thus, we also tested the ability of such copolymers to generate 
19F-MR signals.  
Materials and Methods. Fluorinated nucleic acid residues were incorporated into ODN by 
using automated synthesis or via activated esters on ODN 5’-ends. To quantify ODND uptake by 
the cells and to track their stability, we covalently labeled ODN with fluorophores using 
internucleoside linker technology; the FC-modified carrier was synthesized by acylation of 
pegylated polylysine graft copolymer with perfluoroundecanoic acid (M5-gPLL-PFUDA). 
Results. ODN with a single FC group exhibited a tendency to form duplexes with higher melting 
points and with increased stability against degradation when compared to control non-modified 
ODNs. ODND carrying fluorinated residues showed complex formation with M5-gPLL-PFUDA as 
predicted by molecular dynamics simulations. Moreover, FC groups modulated the specificity of 
ODND binding to the STAT3 target. Finally, FC modification resulted in greater cell uptake (2 to 
4 fold higher) when compared to the uptake of non-modified ODND as determined by 
quantitative confocal fluorescence imaging of A431 and INS-1 cells.  
Conclusion. ODND modification with FC residues enables fine-tuning of protein binding 
specificity to double-strand binding motifs and results in an increased internalization by A431 and 
INS-1 cells in culture. Our results show that modification of ODN termini with FC residues is both 
a feasible and powerful strategy for developing more efficient nucleic acid-based therapies with the 
added benefit of allowing for non-invasive MR imaging of ODND therapeutic targeting and 
response. 
Key words: fluorocarbon, oligonucleotide, magnetic resonance imaging, confocal microscopy, STAT3. 
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Introduction 
Short oligonucleotides and their mimics (such as 
siRNA, oligonucleotide decoys, aptamers, locked and 
peptide- nucleic acids and others [1]) are the essential 
components of a plethora of emerging therapeutics 
designed for targeting and treating multiple diseases 
[2]. These therapies aim to manipulate the 
transcription and translation of a growing number of 
genes and proteins identified as causally linked to 
many diseases and some oligonucleotides may serve 
equally well as diagnostic agents via their capacity to 
be imaged [3-5]. Non-viral delivery of therapeutic and 
theranostic oligonucleotide-based constructs and their 
mimics generally requires protecting small 
oligonucleotides (ODN) from rapid removal and/or 
degradation in vivo which occurs due to their short 
circulation blood half-lives [6, 7]. In general, ODN are 
protected from the biological environment by either 
chemical modification of nucleotide units [8], or by 
encapsulation and/or by formation of complexes with 
synthetic carrier macromolecules with concomitant 
partial condensation into smaller structures. The latter 
approach most frequently relies on the attractive 
forces between the positively charged binding 
elements within the carrier and the negatively 
charged ODN resulting in polyionic interactions and 
may not be suitable for peptide nucleic acids and 
morpholinos. The latter could be induced by 
polyadenylation [9], or non-covalent addition of 
cell-penetrating peptides [10]. In most cases polyionic 
interactions can be fine-tuned to support the required 
formation of the protective complex and as a 
prerequisite for efficient interaction with the 
negatively charged cell surface. The limitation of this 
approach is that polyionic complexes show toxicity in 
vivo [11-13]. Within the last two decades a significant 
synthetic effort was made to provide an alternative to 
polyionic interactions. In particular, lipid and sterol- 
modification of ODN (reviewed in [14, 15]) as well as 
more complex multi-component systems of 
interaction-promoting mediators [16] showed 
promise in improving ODN delivery into cells [15, 17, 
18]. A separate and highly attractive emerging 
approach is to utilize the interactions between 
fluorinated moieties introduced into the ODN and 
ODN-like molecules [19-21]. For decades, fluorine 
substituents served as common components in 
pharmaceuticals, particularly for applications in 
oncology in which about 50% of the marketed drugs 
were fluorinated, including multiple antineoplastic 
agents (e.g. fluorinated taxane and 5-fluorouracil) 
[22]. Fluorinated molecules tend to favor 
fluorine-dominated phases and engage in highly 
specific fluorine-fluorine interactions as a result of 
simultaneous hydrophobic and lipophobic 
electronegativity of fluorinated groups that have large 
molecular cross-sectional areas [23]. Such interactions 
facilitate interfacial assembly of nanoparticles and 
facile enrichment of engineered biomolecules carrying 
fluorinated tags [24]. As a consequence of 
fluorine-fluorine interactions, macromolecules 
carrying FC moieties exhibit a tendency to form 
supramolecular structures which were initially 
postulated to facilitate their penetration into the cells 
[19]. The internalization is also facilitated by a 
decrease of the diameters of nanoparticles as in the 
case of peptide nucleic acid carrying FC moieties [25]. 
Recent research demonstrated that fluorinated 
residues introduced into single-component or 
multi-component positively charged branched 
carriers resulted in improved transfection [26] and 
enabled gene editing [27]. Therefore, the majority of 
research so far has been focused on self-assembly of 
fluorinated single-strand ODN into nanoparticles or 
on fluorination of dendrimeric polycations. We 
endeavored to further enhance the therapeutic 
potential of these gene delivery constructs by 
incorporating two additional and as yet untested 
properties of fluorinated residues i.e., 1) the use of 
fluorine-fluorine interactions in maintaining the 
integrity of non-viral theranostic oligonucleotide- 
based constructs; 2) the potential of fluorinated 
molecules to act as highly specific MR imaging probes 
allowing detection and spatial localization of 
fluorinated compounds through the use of 19F 
selective magnetic resonance imaging (MRI), 
reviewed in [28, 29]. The utility of the latter has been 
suggested by demonstrations in vitro of 19F MR signal 
dependence on the presence of specific proteins [30] 
and on activity of a reporter enzyme [31]. Since cells 
internalize duplexes (ODND) much more efficiently 
than single-strand ODN [32], we hypothesized that 
fluorination would further benefit ODND delivery 
into cells. To test this hypothesis, we devised a hybrid, 
water-soluble macromolecular carrier to carry 
covalently linked FC residues and synthesized 
FC-modified ODND cargo molecules (Figure 1). The 
roles of ODND cargo in our research were assigned to 
STAT3-binding ODND constructs due to their 
potential for clinical development as cancer 
therapeutics. Constitutively activated STAT3 is being 
increasingly recognized as playing a pivotal role in 
progression of aggressive neoplasias such as difficult 
to treat head and neck variants and triple-negative 
breast cancer [33-35]. We report here on drug delivery 
and 19F-magnetic resonance imaging (MRI) properties 
of ODND modified with FC groups and their 
complexes with fluorinated macromolecular carriers. 
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Figure 1. A scheme showing major structural elements of fluorescent, Cy3 labeled oligonucleotide duplexes (ODND) used in this work. ODND contained either 
a single- fluorinated 5’-linked perfluorooctylpropyl group (1FO-ODND-Cy3) or two FO groups (2FO-ODND-Cy3). Fluorinated residues are shown in bright green, 
Cy3 fluorophore is shown in magenta. Yellow color of ODN chains shows the areas where phosphodiester bonds were replaced with phosphorothioates in hybrid 
(PS) ODNs. This design can be easily modified for use with different spectral frequencies because any other fluorophore (e.g. IRDye 800CW) can be used in the place 
of Cy3 for labeling ODND. 
 
Materials and Methods 
Synthesis of ODNs with CF3(CF2)7(CH2)3- 
group on the 5’-end 
All synthesized ODNs were 21-mer 
oligodeoxyribonucleotides (for simplicity index d in 
the formulas below was omitted). Two strategies for 
linking fluorine-containing groups to (or introducing 
them synthetically into) the ODNs were used:  
1) the synthesis of FO-oligonucleotides (where 
FO is CF3(CF2)7(CH2)3O-) by using direct chemical 
synthesis on an Expedite 8909 DNA synthesizer and a 
phosphoramidite monomer C8F17CH2CH2CH2OP 
(OCH2CH2CN) N(iPr)2 (fluorous propanol CEP, 
Berry&Associates, Dexter MI) as the last monomer 
during the synthesis; 
2) the synthesis of FCN-oligonucleotides (where 
FCN is CF3(CF2)7(CH2)3 NHCO(CH2)9O-) by using 
post synthetic modification of a fully protected ODN 
on controlled pore glass (CPG) by linking of 
3-(perfluorooctyl)propylamine to the activated 
carboxy group on ODN. 
Strategy 1 Method 
For standard coupling we used Ultramild CE 
Phosphoramidites (Glen Research), dC*- or 
T*-amidite- (synthons with the TFA-protected 
amino-linkers) synthesized as described before [36]. 
Monomer phosphoramidite CF3(CF2)7(CH2)3O- 
P(OCH2CH2CN) N(iPr)2 (250 µmoles) were dissolved 
in 3 ml of acetonitrile and used at the last step of the 
synthesis [37]. For synthesis of phosphorothioates the 
oxidation and the sulfurization steps were performed 
as described in [38]. After the synthesis, CPG with 
attached oligonucleotides was treated with NH4OH at 
40oC for 2 h. Oligonucleotides were re-precipitated in 
ethanol-sodium acetate twice before loading onto 
HPLC columns. The isolation of FO-oligonucleotide 
was accomplished on C18 reversed phase-HPLC 
(Discovery C18, 250x4.6 mm, 5 µm) using a gradient 
of buffer A (2% acetonitrile in 0.1 M TEAA) and buffer 
B (20% of buffer A, 80% acetonitrile) at 1 ml/min. A 
gradient was formed by ramping 100% buffer A to 
80% B in 22 min followed by 2 min 80% B. The typical 
chromatograms of oligonucleotide mixture analysis 
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are shown in Fig.S1A and S1B as an example of the 
analysis of CF3(CF2)7(CH2)3-O-AGAGATTTAC*GGG 
AAATGGCT, where * stands for the internucleoside 
amino linker -(OCH2CH2)2OCH2CH2NH2 attached to 
phosphorus. The following oligonucleotides with the 
FO group on the 5’-end of the oligonucleotide were 
synthesized using Method 1:  
1. 5’ FO-AGCCAT*TTCCCGTAAATCTCT 3’ 
FO-PS-STAT-SE-T6  
2. 5’ FO-AGAGATT*TACGGGAAATGGCT 
3’ FO-PS-STAT-AN-T7  
3. 5’ FO-AGCC*ATTTCCCGTAAATCTCT 3’ 
FO-PO-STAT-SE-C4  
4. 5’ FO-AGAGATTTAC*GGGAAATGGCT 
3’ FO-PO-STAT-AN-C10  
5. 5’ FO-AGAGATTTAC*GGGAAATGGCT 
3’ FO-PS-STAT-AN-C10  
The above oligonucleotides were designed in a 
way that sense and antisense strands could form 
decoys for STAT3. The positions of bases linked via 
phosphorothioate bonds are indicated in bold, 
whereas phophodiester-linked bases are shown with 
plain text and the numbers after the base indicate the 
position of the internucleoside amino linker.  
Strategy 2 Method 
The synthesis of fluorinated ODN does not 
necessarily require the use of fluorinated synthons. 
Fluorinated residues were also introduced by using 
ODNs terminated with activated carboxyls as 
precursors resulting in FCN-oligonucleotides bearing 
heptadecafluoroundecylcarbamoylnonyl groups. 
First, ODNs with N-hydroxysuccinimide esters 
(5’-NHS) on the 5’-end oligonucleotides were 
synthesized by using standard monomers and 
5’-carboxy-modifier C10 (Glen Research) for the last 
coupling step. Second, 3-(perfluorooctyl)propylamine 
was linked to the activated oligonucleotide directly 
after the synthesis. 0.12 ml of methanol solution of 
3-(perfluorooctyl)propylamine (50 mg/ml) and 4 µl 
triethylamine were added to 15-25 mg CPG with fully 
protected oligonucleotide carrying 5’-NHS group, and 
after 3-5 hours at room temperature CPG was washed 
with methanol. Deprotection was performed by using 
concentrated NH4OH at 55°C overnight. 
Oligonucleotides were re-precipitated by ethanol- 
sodium acetate twice before HPLC purification (see 
Fig.S2). 
The following oligonucleotides with FCN on 
5’-end (FCN-ODN) were synthesized using Method 2: 
1. 5’ FCN-CGATGTGGGACTTTCCAGGCT 3’ 
FCN-PS-IGL-AN  
2. 5’ FCN-AGCCTGGAAAGTCCCACATCG 
3’ FCN-PS-IGL-SE  
3. 5’ FCN-CGAGATTTACGGGAAATGGCT 
3’ FCN-PS-STAT-AN  
4. 5’ FCN-AGCCATTTCCCGTAAATCTCG 3’ 
FCN-PS-STAT-SE  
HPLC analysis of fluorocarbon-modified ODNs 
was performed by using either C18, or CN columns 
with characteristic differences in retention times 
noted for all tested 21-mer ODNs (Table S1).  
ODN modification with cyanine fluorophores 
To 5 nmol of FO-AGAGATTTAC*GGGAAA 
TGGCT, FO-AGAGATTTAC*GGGAAATGGCT or 
FO-AGCC*ATTTCCCGTAAATCTCT dissolved in 35 
µl of 0.1 M NaHCO3 were added 5-6 µl of 5 mM 
Cy3-NHS ester (GE Healthcare Life Sci.) or 7.5 mM 
IRDye 800CW NHS ester (Li-COR Biosciences). The 
reaction mixture was kept at room temperature 
overnight with agitation. After adding 30 µl H2O, 
ODN were loaded on Bio-Spin P6 columns (Bio-Rad) 
and purified according to the standard protocol 
described above. HPLC analysis of FO-AGAGATT 
TAC*Cy3GGGAAATGGCT is shown in Figure S3.  
Molecular dynamics simulations 
Molecular dynamics simulations in a molecular 
operation environment (MOE) was accomplished by 
using MOE2015.10 and MOE2016 software (Chemical 
Computing Group, Montreal CA) [39]. The models of 
ODND probes were placed in a simulated 
NaCl/water cell environment with n=8 margin and 
after calculating partial charges and potential energy 
minimization by applying assisted model building 
with energy refinement (Amber10:EHT) force field. 
This is an all-atom forcefield combining EHT and 
Amber10, parameterized for proteins and nucleic 
acids as well as for small molecules according to 
2D-extended Hückel's theory conventions [40]. 
Simulations were performed by using the 
Nosé-Poincaré-Andersen (NPA) algorithm with a 
0.001 ps time step. 
ODN probes, spectroscopy and melting 
behavior 
ODND probes were prepared by mixing 
approximately equimolar amounts of the 
corresponding complementary ODN dissolved in 25 
mM Hepes, 1 mM MgCl2, 50 mM NaCl, pH 7.4. One of 
the complementary ODN used in these experiments 
contained the covalently linked fluorophore. The 
solutions were heated to 95°C for 5 min to dissociate 
intra-strand secondary structures and allowed to cool 
at room temperature to attain equilibrium. 
Fluorescence emission spectra of ODND or 
single-strand ODN (λem=500-650 nm, Cary Eclipse 
spectrofluorometer) were collected at a concentration 
of 2 µM by using λex=488 nm. The fluorescence 
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intensity of ODNs and ODND was normalized by the 
concentration of Cy3 determined from the absorbance 
spectra (λmax=552 nm, ε552=150000 [M.cm]-1). Melting 
behavior was studied using a Hitachi U-2900 
spectrophotometer equipped with a thermoelectric 
cell holder and a temperature controller. ODND were 
diluted in 10 mM sodium phosphate, 0.15 M NaCl, pH 
7.4 for melting experiments.  
Stability in cell culture medium and 
electrophoretic mobility shift assay (EMSA) 
The conditioned DMEM cell culture medium 
was obtained after culturing A431 cells (human 
epidermioid carcinoma, ATCC CRL-1555) for 1-2 days 
after which it was filtered through a 0.22µm Millipore 
Express PLUS Membrane and stored at 4oC. ODND at 
0.5 µM dilution was incubated in 50% conditioned 
medium either at RT or at 37oC. For EMSA, IRDye 
800CW-labelled ODND (0.04 pmol, final 
concentration 3-4 nM) was incubated with 10-20 µg 
A431 nuclear extract (isolated as described in [41]) in 
20 mM HEPES, 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM 
EDTA, 25% v/v glycerol, 0.5 mM 
phenylmethylsulfonyl fluoride, 5 µg/mL leupeptin, 
100 µg/mL aprotinin, 1 µg/mL pepstatin for 30 min 
RT in a volume of 10-15 µl in the presence of protein 
binding buffer (10 mM Tris, 100 mM KCl, 2 mM 
MgCl2, 0.1 mM EDTA, 0.1 mg/mL tRNA, 10% v/v 
glycerol, 0.25 mM DTT, pH 7.5). Samples were loaded 
and run on 15% TBE Ready Gels (Bio-Rad 
Laboratories, Hercules CA) with 0.5×TBE buffer. The 
gels were imaged and digitized using an Odyssey 
Infrared Imaging system (Li-Cor Biosciences, Lincoln 
NE) using simultaneous solid diode excitation at 685 
nm (IRDye-680 STAT3 probe, Li-Cor) and 785 nm 
(800CW-labeled ODND). TIFF images (16 bit) were 
analyzed, colorized and fused using ImageJ software 
[42].  
M5-gPLL-PFUDA synthesis 
The synthesis, properties and purification of 
M5-gPLL graft copolymer were described in detail in 
[43, 44]. Briefly, methoxy PEG succinimidyl 
carboxymethyl ester (m.w. 5000, JenKem Technology) 
was used to modify 30% of TNBS-reactive amino 
groups of poly-L-lysine (m.w. 21 KDa, DP 100, PDI 
1.12, Alamanda Polymers) with subsequent 
purification of the product on UFP-100 ultrafiltration 
cartridges (GE Healthcare Life Sciences). Thirty mg 
(approximately 0.15 µmol) of M5-gPLL was dissolved, 
with heating in 1 ml of dry acetonitrile. Ten µl (60 
µmol) of diisopropylethylamine (DIPEA) and 8 µl of 
15.5 mM (124 nmol) Alexa Fluor 488 NHS ester 
(ThermoFisher Scientific) were added to M5-gPLL 
solution and incubated for 2 h under argon; equimolar 
amounts of perfluoroundecanoic acid (PFUDA) and 
HOBt (80 µmol each) were combined with 160 µmol 
EDC (Sigma-Aldrich) in 2 ml dry acetonitrile and 
mixed until complete solubilization. The solution was 
added to M5-gPLL, followed by 60 µmol DIPEA, 
sealed under argon and mixed overnight. The solvent 
was removed in vacuum and solids were solubilized 
in 10 ml water. After the addition of 20 ml of acetone 
and 40 ml of ethyl acetate, the lower phase was 
separated and the extraction procedure repeated once. 
Final purification was accomplished by dialysis 
against 30% isopropanol/water using 10 kDa cutoff 
membrane cartridges (ThermoFisher Scientific). The 
purity of M5-gPLL-PFUDA was verified by 
size-exclusion HPLC on Superose 6 Increase 10/300 
GL column (GE Healthcare Life Sciences) eluted with 
0.1 M ammonium acetate.  
ODN duplex M5-gPLL-PFUDA binding 
experiments 
Ten μL of 5 μM ODND solution was mixed with 
M5-gPLL-PFUDA solution at a ratio of 1-20 moles of 
M5-gPLL-PFUDA per ODN (ether modified with FO, 
or control) in a total of 35μL HBS, pH 7.5 and 
incubated at room temperature for 2h. Samples were 
loaded and subjected to electrophoresis on 2% agarose 
gel in 0.5XTBE buffer for 45min, 100v. The gels were 
imaged on an EpiChem III system (UVP BioImaging 
System, Upland, CA 91786) equipped with a 
Hamamatsu CCD camera and the obtained TIF 
images of gels were analyzed using ImageJ (NIH 
software) [42]. Fluorescence lifetime was measured as 
described in [45, 46] using 520-540 nm excitation and 
580 nm long-pass filter; time resolved fluorescence 
was registered using a CCD camera coupled to a 
gated-image-intensifier (LaVision Gmbh, Germany) 
that provides a 300 ps time resolution.  
ODN duplex cell uptake experiments 
A431 cells were maintained in DMEM medium 
(Gibco)/ 10% fetal bovine serum (FBS) (Invitrogen). 
INS-1 cells [47] (generously provided by Dr. Anna 
Moore, Massachusetts General Hospital, Charlestown 
MA) were maintained in RPMI medium (Gibco) 
supplemented with 10% FBS. Cells were seeded on 
coverslips in 12-well plates. After the cells were 
60-70% confluent, ODND were added to the cells at a 
final concentration of 0.5 μM and incubated 
overnight. The cells were washed three times with 
PBS and fixed by incubating for 15 min in 4% 
formaldehyde. For individual cell delineation, plasma 
membranes of fixed cells were stained using 
anti-EGFR (Cetuximab)- Alexa Fluor 488 conjugate, 
or, alternatively, by 5-min incubation in the presence 
of 5 µM Alexa Fluor 488 hydroxysuccinimide ester. 
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The cells were mounted in Vectashield medium with 
DAPI (Vector Laboratories, Burlingame, CA) and 
sealed on slides. The slides were examined using a 
Leica TCS SP8 confocal microscope (Leica 
Microsystems, Buffalo Gove, IL) using a 63x/1.4NA 
lens and 95.6 µm pinhole (at 1AU, λem=580 nm) 
resulting in an approximate optical section thickness 
of dz = 1.4 µm. For Cy3 fluorescence 
excitation/registration we used a DPSS 561 nm laser 
line and hybrid photon counting HyD detector (active 
band 563-668 nm). Three to four fields of view were 
imaged in three channels and saved as 16-bit tiff files 
which were analyzed by using ImageJ software as 
follows: first, cell boundaries within the field of view 
were outlined individually with the outline following 
the green channel fluorescence signal representing 
anti-EGFR-Alexa Fluor 488 conjugate binding to cell 
membrane. The ROIs derived from the outlines of 
individual cells were then pasted onto the “red” 
channel images and the corresponding signals in the 
“red” (Cy3) channel were calculated. Fluorescence 
intensities were determined for 30 to 40 cells in three 
to four non-overlapping fields of view and the uptake 
of Cy3-labeld ODND was expressed as mean 
intensity/cell. The fluorescence intensity values were 
compared by using Mann-Whitney non-parametric 
test (Prism 6, GraphPad Software Inc.).  
Magnetic resonance imaging 
Phantoms were prepared by diluting 100 mM 
stock solution of PFUDA in acetonitrile at various 
concentrations. Before imaging M5-gPLL-PFUDA 
alone, the complex of 2FO-PO-Cy3 with 
M5-gPLL-PFUDA were solubilized either in 
acetonitrile or water, respectively. Imaging was 
performed either in NMR spectroscopy tubes or in 0.2 
ml polypropylene PCR tubes. 19F NMR spectra were 
acquired using a Varian Mercury 200 MHz (4.7T) 
NMR Spectrometer and a 3T Achieva whole-body 
MRI scanner (Philips Medical Systems, Best, 
Netherlands). The 19F chemical shifts were referenced 
to sodium trifluoroacetate at 0 ppm. All 1H and 19F 
MRI experiments were performed at 3.0 T (128 MHz 
for 1H) by using a custom-made solenoid T/R coil and 
modular 19F Gateway Interface (Clinical MR 
Solutions, LLC Brookfield, WI). The coil was first 
tuned to the proton resonant frequency and a turbo 
spin echo (TSE) pulse sequence was used to acquire 
1H images. The 1H imaging parameters were: 8 slices 
with slice thickness of 4 mm; field of view (FOV) = 30 
mm × 30 mm with matrix size of 76 × 72; TR/TE = 
3000/70 ms; flip angle (FA) = 90°; TSE-factor = 8; NSA 
= 8. Subsequently, the coil was tuned to 19F resonant 
frequency and 1H images were used to plan the 19F 
MR imaging plane. A 3D ultrashort echo time (UTE) 
pulse sequence was used to acquire 19F MR images to 
maximize signal from 19F, which has a very short T2, 
and thus rapidly decaying MR signal. Feasibility 19F 
MR images were acquired by using the following 
parameters: TR/TE = 300/0.12 ms; flip angle (FA) = 
60°; NSA = 32; 5 slices with slice thickness of 4 mm; 
field of view (FOV) of 30 mm × 30 mm with matrix 
size of 32 × 32, the total acquisition time for 19F 
imaging was 51 minutes. The 19F MR images of 
Cy3-labeled 2FO-ODND complex with 
M5-gPLL-PFUDA were acquired by using UTE 
(TR/TE=600/0.12 ms; FA= 60°), 9 slices with slice 
thickness of 0.9 mm; voxel size=1x1x4 mm, field of 
view (FOV) of 30 mm × 30 mm (11.5 min acquisition 
time with 6xNSA) or with a smaller voxel size of 
0.5x0.5x2 mm (47 min acquisition time with 6xNSA). 
Raw images were imported and reconstructed using 
ImageJ. Signal-to-noise ratios were calculated by 
normalizing the region-of-interest mean intensity 
values by standard deviation of signal noise. 
Results  
ODN synthesis, structure analysis and 
properties of ODNs and ODND 
We synthesized several sense and anti-sense 
ODN encoding STAT3 transcription factor binding 
interferon-gamma activated sequence (GAS), 
TTNCNNNAA. To provide the building blocks of 
5’-perfluorooctylpropyl(FO)- containing ODND 
probes, the sense ODN (FO-ODN) was synthesized 
using a perfluorooctyl-terminated phosphoramidite. 
Several sense ODN were also synthesized using an 
alternative technique that involved linking 
3-(perfluorooctyl)propylamine to 5’-NHS-terminated 
ODN-CPG followed by the cleavage of ODN product 
(FCN-ODNs) from CPG. The ODNs carried a 
hydrophilic internucleoside amino-linker [36, 48] 
which enabled covalent linking of Cy3 dye to ODNs 
with approximately the same stoichiometric yields 
(0.8-1.1 mol/mol) regardless of their composition and, 
importantly, the presence of ODN 
5’-end-modification (Table 1).  
Further, we investigated whether the 
modification of ODNs with either one (1FO), or two 
FO (2FO) fluorinated residues resulted in ODND 
destabilization. This was accomplished by comparing 
melting temperatures (Tm) of FO-ODND and control 
ODND (Table 2 and 2S). As expected, introducing 
three consecutive phosphorothioate bonds at the 3’ 
and 5’- ends of ODN resulted in the lowering of Tm of 
ODND from approximately 71°С for 100% 
phosphodiester-bond linked ODN to 64°С for 
phosphodiester-phosphorothioate hybrid ones 
(abbreviated as PS further on in the text). However, 
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the modification of a duplex with a single FO “tail” as 
well as linking of a single Cy3 fluorophore to the 
internucleoside amino linker did not yield any 
significant destabilization of ODND structure 
(according to the measured changes of Tm) in the 
presence of 0.15M NaCl and the destabilizing effect in 
the absence of NaCl was also negligible (Table 2). 
Changing the position of the fluorophore by linking 
Cy3 to a complementary strand also did not result in 
major changes to Tm values (Table S2). In 2FO-ODND 
samples the analysis of Tm data showed a decrease of 
Tm only if PS bonds were additionally introduced 
during the ODN synthesis (Table 2).  
ODND molecular dynamics simulations 
We selected four different Cy3-modified, red 
fluorescent ODND for further testing (Table 2). The 
structures of these ODND (Fig. 2) were built in silico 
and molecular dynamics in a water-filled cell was 
simulated in molecular operation environment (MOE) 
using an elliptical water/NaCl filled cell with n=8 
solvent margin. Simulation results pointed to minimal 
changes in the structure of phosphodiester duplexes 
after the modification of ODND with one or two 
fluorinated residues, Fig. 2 (B-D). In the case of PO/PS 
ODND, we noted the formation of duplex structures 
with partially unwound terminus or termini at the 
equilibrium, which were favored by simulation 
algorithm only if two FO groups were present. In 
addition, simulations performed in a combined 
water/NaCl solute cell containing two FO-carrying 
ODND pointed to a high probability of inter-duplex 
fluorine-fluorine interactions resulting in the 
formation of dimers (Fig. 2, E).  
 
Table 1. Properties of 21-mer synthetic oligonucleotides with and without covalently linked fluorinated moieties.  
 
* FO = CF3(CF2)7(CH2)3O- 
** ODN samples were analyzed by LC/MS using C18 column separation and Synapt G2si instrument. Column: Waters OST C18, 2.5 µm 2.1x 50mm; Flow rate: 0.2ml/min 
Sample: 10pmol Gradient: mobile phase A: 20mM ammonium acetate; mobile phase B: acetonitrile 
*** The ratios were determined by using the following extinction coefficients: Cy3 (in [mol .cm]-1: ε260=4930; ε552=150000; ODN extinction was determined by using the 
following formula: ε260 = ((nA × 15.4) + (nC × 7.4) + (nG × 11.5) + (nT × 8.7)) × 900. The position of an aminodiethoxyethyl linker is shown by | symbol. 
 
Table 2. The sequences of control and ODN duplexes carrying FO groups with Cy3 fluorophore linked to sense or antisense ODNs 
used in this study.  
 
a) ODNs were labeled with Cy3 at internucleoside linker position (shown in red). The position of an amino linker on a complementary ODN in a duplex is shown by |;  
b) shown as fluorescence intensity (λex=488 nm, λem=552 nm, in AU) normalized by Cy3 concentration (µM). 
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Figure 2. Molecular modeling of PO ODND (A,B) and PS ODND: (A) 1FO-PO-Cy3; (B) 2FO-PO-Cy3; (C) 1FO-PS-Cy3; (D) 2FO-PS-Cy3 (see Table 2). A 
hypothetical dimer of 2FO-PS-Cy3 ODND is shown in E. Fluorine atoms are rendered in green and sulfur atoms are rendered in yellow. Van-der-Waals surfaces (4.5 
Å) of interacting fluorinated residues were calculated and rendered in green, Cy3 dye is shown covalently linked to the amino groups of internucleoside phosphate 
triethylene glycol amino linkers. Amino linkers of complementary ODNs in these duplexes were left non-modified in all simulations. Oligonucleotides carry GAS 
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STAT3 recognition sequence (TTCCCGTAA). The structures were obtained by using molecular dynamics simulations in MOE by applying assisted model building 
with energy refinement (Amber10:EHT) force field using a simulated elliptical water/NaCl solvent cell (n=8 margin). 
 
Figure 3. Electrophoretic analysis of Cy3-labeled ODN duplex probe stability in conditioned cell culture medium. A- 3% agarose gel electrophoresis of FO-ODND 
or control ODND samples (2 µM ODND) incubated in the presence (+) or absence (-) of A431 cell conditioned medium for 16 h at room temperature; B- 15% 
polyacrylamide gel electrophoresis (0.5xTBE) of the same samples incubated for 16 h at 37oC. The first lane of the gels shows a pre-stained 50-200 bp ODN ladder. 
The images were acquired using SybrGold filters and are inverted for better viewing. The arrow shows the position of ODND and arrowhead shows the position of 
2FO-ODND migration, respectively; C- quantification of intact and degraded fractions of ODND as determined by using ROI measurements of integrated band 
intensity.  
 
Biological stability of ODND and STAT3 
binding affinity 
The remarkable differences in simulated ODND 
structures at equilibrium in solution at ambient 
temperatures suggested potential differential stability 
to degradation in biological milieu. To investigate this 
we first analyzed the stability of the four chosen 
ODND structures against degradation using the 
medium conditioned by A431 human squamous cell 
carcinoma culture. Agarose electrophoresis showed 
that all four duplexes were partially associated with 
the medium components to a similar extent regardless 
of the presence or absence of FO groups. In addition, 
agarose electrophoresis also showed a somewhat 
slower migration of FO-modified ODND suggesting a 
potential interaction with the gel matrix (Fig. 3A). 
More detailed analysis of the same samples incubated 
at 37oC overnight in the presence of conditioned 
medium instead of room temperature showed that all 
ODND exhibited at least some degree of degradation 
(Fig. 3B). All ODND tested showed association with 
cell culture media proteins that ranged between 7.5% 
and 12%. In the samples containing 2FO-PO duplex 
(Table 2) the degradation did not exceed 20% (Fig. 3B), 
whereas duplexes 2FO-PS and 1FO-PS, were more 
affected by the degradation. While only 33-35% of 
FO-containing PS ODND were degraded, in the 
absence of FO groups, degradation of ODND 
exceeded 50% (Fig. 3). As the next step we studied the 
effect of fluorination on binding of GAS-sequence 
encoding ODND to STAT3 in the nuclear lysates of 
A431 cells overexpressing this transcription factor. By 
conjugating a near-infrared NIR Dye 800CW to an 
internucleoside amino linker instead of Cy3 we 
achieved high sensitivity of ODND detection enabling 
the tracking of ODND binding with STAT3 by using 
electrophoretic shift mobility assay (EMSA, Fig. 4). 
The assays demonstrated that all PS ODN devoid of 
FO groups (green-pseudocolor fluorescence) and a 
control commercially available near-infrared ODND 
probe (red pseudo color fluorescence) showed similar 
patterns of electrophoretic mobility shift in the 
presence of nuclear lysate.  
The addition of an excess of the non-labeled 
ODND resulted in the elimination of the band 
corresponding to STAT3-ODND complex (marked 
with an asterisk, Fig. 4, lane 3) which allowed 
determination of the specificity of ODND-STA3 
binding. The addition of anti-STAT3 antibody to the 
mixture resulted in detectable supershift Fig. 4, lane 8, 
arrowhead). The introduction of a single FO group 
resulted in an increase of ODND binding specificity as 
the intensity of a non-specific band decreased (Fig. 4, 
lane 5), while 1FO-ODND was still able to recognize 
STAT3. However, unlike ODND and single FO-group 
modified ODND, two FO groups in the composition 
of 2FO-ODND probes resulted in a loss of binding 
either to STAT3, or to non-specific components in the 
lysate.  
Cell culture experiments 
We further compared the intracellular 
fluorescence intensity of individual cells to determine 
whether Cy3-labeled ODND exhibit any measurable 
differences in cell uptake depending on the presence 
or absence of FO residues in their composition. We 
examined monolayer cell cultures after incubation at 
37oC overnight in the presence of various 0.5 µM 
Cy3-labeled ODND probes. The comparison of 
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Cy3-labeled PS, 1FO-PS, 2FO-PS and 2FO-PO ODND 
probes showed that the FO-modified ODND were 
internalized into cells of two tumor cell lines (A431 
and INS-1) at significantly higher levels than control 
ODND that were lacking FO groups (Fig. 5). The 
efficacy of ODND probe internalization (expressed as 
mean fluorescence intensity of a single cell optical 
section) in INS-1 cells showed higher uptake of 
fluorinated ODND probes. The mean cell fluorescence 
in INS-1 cells was approximately 3-times higher in the 
case of 2FO-PS than PS ODND probe, Fig. 5A-C. The 
levels of uptake of all ODND were higher in A431 
cells then in INS-1. For example, in PS ODND the 
addition of each FO residue to ODND resulted in 
statistically significant doubling of intracellular 
fluorescence reflecting the enhanced efficacy of 
uptake, with 2FO-PS modified duplex probes 
showing at least a 5-times higher uptake than the PS 
control based on mean cell fluorescence values (Fig. 
5D-F).  
 
 
Figure 4. Electrophoretic mobility shift assay performed using FO-containing and control ODN duplex probes. IRDye 800 CW-labeled ODND, i.e. PS, 1FO-PS, 
2FO-PO as well as a control duplex (4 pmol IRDye-680 STAT3 probe, Li-Cor) were incubated in the presence (lanes 2,3,5,7,8) or the absence (lanes 1,4,6) of 24µg 
A431 nuclear extract and resolved in 15% polyacrylamide TBE gels. A 100-fold molar excess of non-labeled ODND competitive inhibitor was added to the sample of 
lane 3. Three µg of rabbit polyclonal anti-STAT3 antibody was added to the sample of lane 8. Lanes 1-3 and 8 - PS ODND; lanes 4-5 - 1FO-PS; lanes 6-7 - IRDye-680 
STAT3 probe (positive control). Asterisks mark STAT3 band (position determined by using competitive inhibition); arrowhead points to a supershifted band. S- 
IRDye 800CW-labeled protein molecular weight markers. 
 
Figure 5. The uptake of Cy3-labeled ODND (0.5 µM, 18h) with or without 5’-linked FO groups in cell culture of human cells. (A, B) confocal multichannel 
fluorescence microscopy of insulinoma INS-1 cells after an overnight incubation with PS-Cy3 (A) or 1FO-PS-Cy3 (B) ODND. (D, E) confocal microscopy of human 
squamous cell carcinoma A431 cells after incubating with 1FO-PS-Cy3 (D) or 2FO-PS-Cy3 (E) Blue - DAPI. Green – anti-EGFR-AF488 (A431 cells) or AF488-NHS 
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(INS-1). Red – Cy3 (ODND probes). (C, F) quantification of the uptake using mean intensity measurements of individual cells (C) INS-1; (F) A431; acquired in the 
red channel as described in Materials and Methods. Column statistics and P values were determined by using non-parametric Mann-Whitney test, n=30-60 cells; (G, 
H) fluorescence microscopy of 2FO-PS-Cy3 (red) complex with M5-gPLL-PFUDA (AF488-labeled, green) after a 2 h (G) or 24h (H) incubation with A431 cells.  
 
Figure 6. 19F/1H MR imaging and FO-ODN binding to M5-gPLL-PFUDA carrier. A- 1H (TSE pulse sequence) and corresponding 19F MR images (UTE pulse sequence) 
of M5-gPLL-PFUDA (at 6.6 mM PFUDA linked to M5-gPLL) and two PFUDA standards (1 and 10 mM). Note the higher MR signal in M5-gPLL-PFUDA at lower PFUDA 
concentration than in the 10 mM PFUDA standard acquired as described in Materials and Methods. Calibration scales showing SNR values are on the left, 1 cm bar 
is shown at the bottom; B- agarose electrophoresis results showing the comparative binding of near-infrared IR Dye 800CW fluorescent-labeled PS- and 1FO-PS 
ODND to M5-gPLL-PFUDA; C- quantification of Cy3-labeled ODN binding to M5-gPLL-PFUDA using near-infrared agarose gel imaging and analysis. The ratios are 
shown as mol ODN/mol M5-gPLL-PFUDA. D- fluorescence lifetime maps of Cy3 fluorophore linked to ODND measured in 0.1 µM samples of PS, 1FO-PS ODND 
as well as free and M5-gPLL-PFUDA bound 2FO-PO and 2FO-PS ODND (showed in a box). The average FL (measured in ns) is shown next to the maps and the 
pseudocolor lifetime scale is shown on the left; E- the comparison of red fluorescence of 4.5 µM 2FO-PO-Cy3 (sample 1) and 4.5 µM 2FO-PO-Cy3/M5-gPLL-PFUDA, 
2 mM PFUDA (sample 2); F – Maximum intensity pixel projection reconstruction 19F MR image (n=6 slices) of samples 1 and 2 acquired by using UTE pulse sequence 
in two projections: sagittal (above) and transverse (below). 
 
ODND binding and delivery by 
M5-gPLL-PFUDA 
We used covalent linking of a fluorinated 
“adaptor molecule” to M5-gPLL, a conjugate of 
polylysine backbone and grafted methoxyPEG chains 
[43] to synthesize a carrier for the delivery of 
fluorinated ODND into cells. By using acetonitrile as a 
solvent for both M5-gPLL and perfluoroundecanoic 
acid (PFUDA) we achieved efficient coupling of 
PFUDA to primary amino groups of M5-gPLL via a 
two-step carbodiimide activation and coupling 
procedure. The resultant purified conjugate of 
M5-gPLL and PFUDA was fully soluble in 
acetonitrile. While PFUDA alone is insoluble in water, 
the purified M5-gPLL-PFUDA was water-soluble if 
the initial pegylation degree was 25-30% of total 
available primary amino groups of PLL. Fluorine 
nuclear magnetic resonance (NMR) spectra of 
M5-gPLL-PFUDA solutions and PFUDA standards 
were then performed at high filed to determine 
PFUDA concentrations. Integration of aliphatic 
fluorine resonances (from -35 to -45 ppm, with 
exception of the line of perfluoromethyl fluorines set 
at zero ppm shift, see Fig. S5A) allowed determination 
of the concentration of PFUDA in M5-gPLL-PFUDA 
(Fig. S5E). An expected broadening of peaks was 
observed in both NMR spectra due to the increased 
viscosity of polymer carrier (Fig. S5 C, D). On T1 
weighted images the 19F MR signal intensity obtained 
by using ultra-short echo pulse sequence was higher 
at lower concentrations of fluorine than 19F MR 
intensity signal of PFUDA (Fig. 6A) suggesting the 
decreased mobility of perfluorinated acyl chains in 
the vicinity of PLL backbone due to the high local 
viscosity compared to PFUDA solutions in 
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acetonitrile. As a result, we observed a 5.7-fold 
reduction in T1 relaxation time (2000 ms vs. 350 ms) 
and this change translated into a higher MR signal 
intensity. The comparison of normalized signal to 
noise ratios (SNR) showed a 1.6-times higher SNR in 
the case of M5-gPLL-PFUDA than 10 mM PFUDA 
standard (20.5 vs. 13.0). We then made an observation 
that both duplexes, whether they were modified with 
3-perfluorooctylpropyl residues or not, were forming 
complexes with M5-gPLL-PFUDA carrier polymer 
(Fig. 6B). However, only ODNs bearing FO residues 
such as 1FO-PS were bound at 100% to 
M5-gPLL-PFUDA at the molar ratio of 1:20 
(ODND/carrier) while control PS was binding to the 
carrier at lower levels (Fig. 6C). These results were 
obtained by integrating fluorescence signals of the 
fraction of free ODND probes covalently labeled 
either by using Cy3 or 800CW fluorophores. This was 
necessary because both cyanine fluorophores used for 
coupling to ODNs showed a considerable increase of 
fluorescence intensity, i.e. ODN-linked Cy3 showed a 
20% increase and NIRDye 800CW-linked showed a 
50% signal intensity increase after binding to 
M5-gPLL-PFUDA compared to the free 1FO-PS 
ODND. These results suggest a change in fluorophore 
microenvironment resulting in higher fluorescence 
yields. Our measurements of Cy3 fluorescence 
lifetime (FL) showed that after the binding to 
M5-gPLL-PFUDA, the lifetime of Cy3 increased from 
0.74±0.04 to 1.05±0.02 ns in the case of 2FO-PO and 
from 0.95±0.04 to 1.10±0.06 ns in the case of 2FO-PS 
(Fig. 6D). The relative increase of 2FO-PO-linked Cy3 
fluorescence intensity was also present when two 
samples containing equal concentrations of 
2FO-PO-Cy3 were subjected to fluorescence imaging 
either in the absence of (sample 1, Fig. 6E) or in the 
presence of 50 mg/ml M5-gPLL-PFUDA (sample 2, 
Fig 6E) at an approximate molar ratio of 1:1000 
(ODND/carrier). Sample 2 had 3.8-times higher 
fluorescence intensity of Cy3 than sample 1. 19F MRI 
of samples 1 and 2 demonstrated that the bound 
complex of 2FO-PO-Cy3 with M5-gPLL-PFUDA 
carrier was detectable with imaging at a concentration 
of PFUDA in the range of 1.5-3 mM (Fig. 6 F). Cell 
uptake experiments (Fig. 5G, H) performed by 
combining 2FO-PO-Cy3 with M5-gPLL-PFUDA 
carrier showed that the complex between 
2FO-PO-Cy3 had very high stability and that both 
ODND and M5-gPLL-PFUDA were localized inside 
the same intracellular compartments after a 
prolonged incubation in cell culture.  
Discussion 
Numerous reports suggest that covalent 
modification of oligonucleotides with sterols [49, 50] 
or conjugation with lipids (reviewed in [15, 51]) can 
serve as a means of increasing affinity to plasma 
membranes as an alternative to more common ODN 
charge neutralization with polycations. There is an 
important distinction between lipids and/or sterols 
[52], and fluorocarbon residues as ODN modifiers as 
the latter requires only simple, relatively short 
fluorinated carbon chains due to the strength of the 
hydrophobic/lipophobic effect of fluorine [53, 54]. 
Therefore, we explored a combined approach to 
fluorescent ODND probe delivery and protection by 
using fluorocarbon (FC) chemistry. We expected that 
FC tails would associate non-covalently with each 
other to create transient defects in plasma membrane 
resulting in the internalization of individual ODN or 
their supramolecular associates and furthermore that 
hydrophobic interaction of FC chains with plasma 
membrane would result in an increase intracellular 
accumulation of ODND. In addition, we assumed that 
fluorine-fluorine interactions could serve as a driving 
force capable of promoting the association of 
fluorinated ODN with fluorinated polymers that 
would then act as carriers of ODND (showed 
schematically in Fig. S4). We reasoned that by 
modifying the residual amino groups of graft 
copolymer M5-gPLL with FC residues, the resulting 
copolymer would be capable of participating in a 
spontaneous complex formation with FO-ODND due 
to non-covalent interactions between FO-ODND and 
M5-gPLL carrying PFUDA “tails”. The advantage of 
fluorinated carriers and their complexes with 
FO-ODNs is in that these complexes or 
M5-gPLL-PFUDA alone are potentially detectable in 
the tissue by using 19F-NMR spectroscopy or MRI. 19F 
MR imaging is lower than sensitivity of proton MRI 
assisted with traditional paramagnetic contrast agents 
and it is unlikely that the sensitivity of detection of 
fluorinated polymer-ODND complexes at realistic 
doses required for ODND delivery in vivo will be on 
par with 19F NMR and MRI of previously studied 
perfluorocarbon emulsions with much higher content 
of fluorine [55-57]. However, the sensitivity can be 
improved by using building blocks containing 
fluorine atoms with equivalent chemical shifts, e.g. 
perfluoro-tert-butyl groups which are useful for a 
range of diverse applications, from cell tracking in 
vivo [58] to drug delivery applications of fluorinated 
polymers [59]. Parallel efforts directed at improving 
sensitivity and acquisition times, i.e. the 
implementation of clinically acceptable higher field 
strengths in conjunction with pulse sequence 
optimization [60, 61] and the use of three-dimensional 
compressed sensing [62], are transforming 19F MRI 
into a clinically acceptable modality [63].  
The choice of ODN sequences used in our work 
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was based on transcription factor-binding ODND 
decoys [64]. Such decoys were previously devised for 
blocking or attenuating STAT3- dependent 
transcription of genes associated with cancer 
progression [65, 66] which are implicated in poor 
cancer prognosis [33]. Therefore, to compare cellular 
uptake of ODND we chose cells overexpressing 
STAT3, which is involved in regulation of their 
survival [67, 68]. 
The experiments performed with ODND 
modified with perfluorocarbons and Cy3 
fluorophores (Table 2) showed results that were 
consistent with minimal loss of thermal and 
thermodynamic stability reported by others [69]. 
Moreover, FO residues provided protection from 
ODND degradation in conditioned cell culture 
medium (Fig. 3) while preserving the ability to bind 
STAT3 with higher specificity than FO-free ODND 
(Fig. 4). While two FO residues interfered with STAT3 
binding, one could use reactive functional groups on 
the ODN ends for generating reversible end caps [70] 
that dissociate after the uptake by live cells thereby 
abrogating such interference.  
The influence of fluorinated groups on cell 
uptake was investigated by using semi-quantitative 
confocal microcopy-assisted measurements of 
fluorescence intensity of cell optical sections [71]. 
There are several potential advantages of this 
strategy: 1) high sensitivity and specificity; 2) the 
uptake in individual attached cells could be compared 
by outlining cell membranes that define cell-specific 
region of interest; 3) lack of a contribution of 
non-specific fluorescence (e.g. as a result of binding to 
extracellular substrate). In our experiments 
fluorinated groups were clearly capable of assisting in 
transporting ODND into the cells through plasma 
membrane. The exact mechanism of such transport 
still has to be studied in more detail. Though silencing 
of ApoB mRNA by FC-end modified siRNA in HepG2 
cells has been recently reported [21], FC-end modified 
silencing construct was delivered into the cells via 
transfection and not by a simple co-incubation.  
It is also important to consider the use of 
water-soluble synthetic macromolecules as carriers of 
FO-ODND (see Fig. S4). Zero-energy Van der Waals 
interaction surfaces in the surroundings of FC 
residues suggested a high probability of interactions 
between the FO group of the ODND and 
M5-gPLL-PFUDA in simulated water solutions. These 
simulations (Fig. S4) were corroborated by the 
analysis of complex formation with M5-gPLL-PFUDA 
(Figs. 5 and 6). In addition, a shift to longer 
fluorescence lifetimes of Cy3 was consistently 
observed if FO-ODND were incubated in the presence 
of M5-gPLL-PFUDA suggesting that Cy3 fluorophore 
was transferred to an environment with higher local 
viscosity within the FC-modified backbone of the 
copolymer.  
In summary, our experiments with fluorescent 
ODND probes carrying either one or two fluorinated 
“tails” show higher ODND stability against 
degradation and significantly higher uptake in cells 
over time in vitro when compared to control ODN 
duplexes. Our results point to a potential use of ODN 
probes with one or more fluorinated residues for 
improving intracellular delivery in vitro and in vivo by 
using non-ionic and non-covalent interactions 
between fluorinated groups and fluorinated 
macromolecular carriers. Such carriers with or 
without bound FO-ODN duplexes have the 
advantage of carrying 19F tags potentially detectable 
by MR in living systems with zero background, i.e. 
the resultant images are not contaminated with the 
proton signal from conventional MRI. The 
experiments designed to optimize the 
macromolecular carriers for fluorinated ODND cargo 
are underway. 
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